This could give it broader therapeutic potential for: As of 2025, Dihexa has not yet entered large-scale, double-blind, placebo-controlled clinical trials for widespread human use
SAMe provides the specific methyl groups required to methylate Myelin Basic Protein (MBP) , the core structural protein of the myelin sheath
However, untreated sleep apnea can undermine the benefits of GLP-1 therapy
Patient genders, ages, and lesion dermoscopic pattern types were retrieved
[3] [4] These may be indirect effects related to dietary changes, altered eating schedules, gastrointestinal discomfort, or the psychological adjustments that accompany significant weight loss